Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Kazakhstan
Kazakhstan: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 49.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Kazakhstan, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Kazakhstan recorded 49.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in 2025.
Compared with earlier readings it is up 11.4% on the previous year and down 27.9% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Kazakhstan peaked at 86.0% in 2016 and was at its lowest, 0.0%, in 2008.
That places Kazakhstan 156th out of 194 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 51.4% | 0.0% | 86.0% | 10 |
| 2020s | 50.8% | 44.0% | 55.0% | 6 |
Countries ranked near Kazakhstan
- 153 Angola 54.0% compare
- 153 Iran 54.0% compare
- 155 Azerbaijan 52.0% compare
- 156 Chad 49.0% compare
- 158 Central African Republic 45.0% compare
- 159 Papua New Guinea 44.0% compare
More health data for Kazakhstan
- Heat deaths vs projected death rates 825.8 (2090)
- Un projection of annual infant deaths 660 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 117,857 (2025)
- Age population, age 25, female, interpolated 113,463 (2025)
- Age population, age 24, male, interpolated 118,755 (2025)
- Age population, age 24, female, interpolated 114,320 (2025)
- Age population, age 23, male, interpolated 121,672 (2025)
- Age population, age 23, female, interpolated 117,102 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Kazakhstan?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Kazakhstan was 49.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Kazakhstan?
- The highest recorded value was 86.0% in 2016.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Kazakhstan?
- The lowest recorded value was 0.0% in 2008.
- How does Kazakhstan rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Kazakhstan ranks 156th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Kazakhstan?
- Over the last ten years it is down 27.9%. The long-run trend across the full record is volatile.
- Where does this Kazakhstan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).